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Resumo: Introdução: Psoríase em placas é uma dermatose crônica que tem um impacto importante 
nas dimensões social e psicológica nos pacientes. Estudos anteriores sugeriram que intervenções 
educacionais e psicológicas podem ser efetivas no gerenciamento da psoríase. Objetivos: 
Examinar as intervenções educativas e psicológicas para psoríase em período de 20 anos (1992 a 
2012). Método: revisão sistemática de literatura nas bases de dados: PubMed/Medline, PsycInfo 
(APA), ProQuest e Pepsic. Resultados: 1359 artigos foram primeiramente selecionados por 
busca computadorizada, dos quais 36 foram analisados por dois revisores. Sete (n=7) estudos 
foram posteriormente selecionados para análise detalhada, sendo um artigo (n=1) de intervenção 
educativa individual, dois (n=2) envolvendo intervenções psicológicas e quatro (n=4) programas 
de gerenciamento de sintomas. Conclusão: Embora a literatura aponte para um crescente número 
de estudos de intervenção para psoríase e variáveis psicológicas, são necessários estudos de maior 
rigor para ajudar os pacientes a lidar com a doença.
Palavras-chave: psoríase, estresse, intervenções. 
Educational and psychological interventions on psoriasis:
a systematic review
Abstract: Background: Plaque psoriasis is a chronic skin disorder that has a major impact on 
patient´s social and psychological abilities. Preliminary studies have suggested that educative 
and psychological interventions may be effective in the management of psoriasis. Objectives: To 
examine the educative and psychological interventions for psoriasis in the last 20 years (1992-2012). 
Methods: A systematic review of literature was conducted in medical and psychological databases: 
PubMed / Medline, PsycInfo (APA), ProQuest and Pepsic. Results: 1359 articles were first selected 
by computerized search, from which 36 were examined by two revisers. Seven studies (n=7) were 
selected to a more in depth analysis, one (n=1) was a single educative intervention, two (n=2) 
involved psychological interventions and four (n=4) were symptom management programmes. 
Conclusion: Although the recent literature shows an increase number of interventions targeting 
psoriasis and psychosocial variables, stronger studies are necessary to help patients deal with the 
disease. 
Keywords: psoriasis, stress, interventions.
Introduction
The skin is the organ that serves as a boundary between the person and the 
environment. By having the same embryonic origin of the central nervous system 
(ectoderm), it represents an important role in emotions, since its innervations are 
linked to several body systems and reacts even to the smallest physical and emotional 
stimulations. It is no wonder that chronic dermatosis demonstrates a signifi cant impact 
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on patients’ quality of life (QoL), as their diseases are internal and public at the same 
time. Among the chronic dermatosis, psoriasis is one of the most representatives, 
whether for its western incidence (around 2%) or because of the psychosocial impact 
caused by the symptoms.
Among the various forms of the disease, psoriasis vulgaris – or plaque-like psoriasis 
– is the most representative and can cover approximately 90% of diagnoses (Griffi ths & 
Baker, 2007). The plaque psoriasis is an infl ammatory disease, with immunological and 
genetic mediation, chronic course and possible periods of remission and relapse (Pereira, 
Brito & Smith, 2012). It is clinically characterized by well-delineated erythematous 
plaque with a silvery-white scale, which may have different sizes and thicknesses 
(Griffi ths & Baker, 2007). In more severe cases, the lesions tend to be uncomfortable, 
disfi guring and itchy, with frequent reports of bleeding and a burning sensation. Although 
there is no precise physiopathological defi nition of psoriasis, it is believed that there is 
an infl ammatory disorder of T lymphocytes, involving cellular differentiation fl aws of 
the keratinocytes and epidermal hyperproliferation (Griffi ths & Baker, 2007; Buske-
Kirschebaum, Kern, Ebrecht & Hellhammer, 2006).
Although psoriasis is a dermatological disease, the growing body of evidence 
presented by the scientifi c community in recent years points to the multifactorial impact of 
the disease, making it the focus of psychodermatology and psychosomatic studies. Among 
the most common comorbidities are: obesity/metabolic syndrome (Noori, Trash & Menter, 
2010) cardiovascular diseases (Schmitt & Ford, 2009; Christophers, 2007) autoimmune 
diseases (Christophers, 2007), such as Crohn’s disease, cancer and lymphomas, alcohol 
intake (Schmitt & Ford, 2009; Kirby et al., 2007; McAleer et al., 2011) and psychiatric 
disorders (Schmidt & Ford, 2009; Biljan, Laufer, Filakovic, Situm & Brataljenovic, 
2009; Russo, Ilchef & Cooper, 2004) such as Major Depression, Obsessive Compulsive 
Disorder and Post Traumatic Stress. Reports of conditions that affect the day-to-day lives 
of patients are also common, such as sexual dysfunction (Gupta & Gupta, 1997; Sapogna, 
Gisondi, Tabolli & Abeni, 2007), suicidal ideation (Gupta & Gupta, 1998; Kurd, Troxel, 
Crits-Christiph & Gelfand, 2010), poor conjugal/family relationships (Pereira et al., 
2012; Campolmi et al., 2012) and low perceived social support (Picardi, Gaetano, Baliva 
& Biondi, 2005). Other studies involving several psychiatric comorbidities of psoriasis 
are discussed by the authors of a recent systematic review (Rieder & Tausk, 2012). The 
results point to a signifi cant overall decrease of stress, and that there is need for further 
studies so that they can improve existing treatments.
Psychosomatic factors, Psychoneuroimmunology, stress and psoriasis
The latest studies on psychosomatics try to rely increasingly on a recent 
interdisciplinary area of research: Psychoneuroimmunology (PNI). An example of this 
is the research on the role of negative emotions in the various body systems. It is known 
that the individual that experiences negative emotions in the face of stressors, over a long 
period, tends to have his nervous system affected, causing the breakdown of the body’s 
harmony (homeostasis) to result in agitation and inhibition in the search for resolution 
of the stressor (allostasis), which consequently changes the balance of neurotransmitters 
and hormones. 
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Throughout the literature, there having been reported confl icting results concerning 
the relation between stress and psoriasis. Reports noted by these authors in clinical 
practice corroborate with some studies (Fortune, Richards, Main & Griffi ths, 1998; 
Zachariae et al., 2004), where patients with psoriasis reported that the exacerbation of 
their symptoms was linked to the occurrence of stressful events. Comparing the stressful 
events of psoriasis patients with other dermatosis, other researches reports (Mahlotra 
& Mehta, 2008; Verhoeven et al., 2009) pointed to a number of everyday situations 
signifi cantly higher for the former. The extent of the injuries measured through clinical 
PASI (Psoriasis Area and Severity Index) was positively correlated to the level of 
perceived stress in another study (Kotrulja, Tradinac, Jokic-Begic & Gregurek, 2010), 
which also showed positive correlations between depression, anxiety state and trait 
anxiety. The reported history of traumatic events in childhood, such as emotional abuse, 
alcohol / drugs and family secrets, was also brought in a greater number of patients 
with psoriasis compared with other dermatosis (Simonic et al., 2010), although the 
presence of these events did not foretell the severity of the injuries.
Under the interdisciplinary perspective of PNI, the interaction between the various 
body systems related stress and psoriasis deserves to be elucidated. The stress response 
activates the hypothalamic-pituitary-adrenal axis (HPA) and the autonomic nervous 
system, which interact with the immune system, allowing it to exacerbate infl ammatory 
responses, such as those occurring in psoriasis (Evers et al, 2010). The activation of 
the HPA axis has as a result of the glucocorticoid cortisol which, besides collaborating 
with the circulatory and muscular reaction in response to the acute stress, also promotes 
the proliferation of mast cells and proinfl ammatory cytokines, which could promote 
the reaction of infl ammatory diseases, such as psoriasis. This mechanism may explain 
the relative worsening of the lesions in stressful events, formerly referred, although we 
have the infl uence of individual variables mediating this process.
The pathogenesis linked to psoriasis is also implicated in the reaction to stress 
(Gulliver, 2008). T-cell activation in the skin promotes an increase in of the traffi c of pro-
infl ammatory cytokines, such as the tumor necrosis factor (TNF-α), interleukin 2 (IL2) 
and interferon-γ, which promote other pro-infl ammatory secretions. At the end of the 
cascade, there is a migration of infl ammatory cells towards the skin, possibly resulting 
in a hyperproliferation of keratinocytes, contributing to the psoriasis’ phenotype. The 
infl ammatory processes linked to the pathogenesis of psoriasis are also common to 
a number of symptoms of the previously commented comorbidities, such as obesity, 
metabolic syndrome, cardiovascular disease and depression (Schmitt & Ford, 2009; 
Schmidt-Ott, Jacobs & Jaeger, 1998). A detailed explanation of the connection between 
the neuroendocrine-immune circuits and the skin is brought by Ralf Paus and colleagues 
in an important literature review (Paus, Theoharis & Arc, 2006).
Concerning the professionals: how much do healthcare professionals know about the 
psychosocial implications of psoriasis
There is suffi cient evidence for psoriasis to be faced as a serious disease, one that 
affects a wide variety of aspects in the life of individuals, regardless of age, and that 
has links with serious comorbidities. Given the possible involvement of psychosomatic 
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factors in the etiology as well as in the progression of the disease, there is a growing 
need to embrace the psychosocial variables in current treatments and also develop 
strategies that involve other health professionals in an interdisciplinary manner, such as 
psychologists and psychiatrists. Currently, the main recommendations for the treatment 
of the disease and management of its symptoms have taken into account broader aspects 
of the subject’s life, focusing on how to face this disease.
It appears, however, that most of the literature reviews involving pathogenic and 
clinical aspects of the disease (Griffi ths & Barker, 2007; Noori et al., 2010; Gottlieb & 
Dann, 2009) rarely mention the need for referral to professionals from the “psy” fi eld, 
except in cases of severe depression and suicidal ideation (Russo et al., 2004). The 
overspecialization (focus on symptoms, rather than the person) can hypothetically be 
one of the major reasons for this neglect with the emotional aspects, since frequently 
professionals – especially dermatologists – who accept the patient at fi rst, are not 
qualifi ed enough to cope with such demands (Picardi et al., 2004; Richards, Fortune, 
Weidmann, Sweeney & Griffi ths, 2004). Patients with psoriasis, acne and eczema were 
interviewed qualitatively to access their relationship with their dermatologists. The 
results indicate that the doctors were considered insensitive, had poor comprehension 
of the implications of the disease and tended to trivialize the patient’s disease (Magin, 
Adams, Heading & Pond, 2009). In another study involving questionnaires sent by 
post to dermatologists from a U.S. state dermatology association (Jafferany, Stoep, 
Dumitrescu & Hurnung, 2010), of the 102 who responded to the survey, only 18% 
expressed clear understanding about psychodermatology and 42% of them felt 
comfortable treating psychodermatosis. However, perhaps the most surprising data 
is the fact that only 32% of doctors had received some sort of training to deal with 
psychodermatosis.
While the need for more training and improvement in the formation of some 
professionals is questioned, some health professionals, usually psychiatrists, 
psychologists and nurses, indicate interdisciplinary referrals and treatments. In a recent 
guide for diagnosis and clinical management of psoriasis (Cohenm Baron & Archer, 
2012), sponsored by the British Association of Dermatologists, the authors recommend a 
comprehensive assessment of psychosocial factors of patients accessing the impairment 
of QoL. For the treatment, the fi rst step would be to educate the patient about the 
disease, emphasizing the management of symptoms – and not the cure – , clarifying 
doubts and possible myths about the disease and teaching the subjects how to apply the 
medication. Furthermore, it is suggested to the clinician to verify the social impact of 
the disease, whether the patient has social support to aid in the treatment, verifying the 
best treatment for each case. However, the guide recommends treatment / psychological 
assistance only when it is decisive to the exacerbation of psoriasis symptoms.
In addition to conventional medical therapies for symptom management, which 
involve pharmacological treatments (topical, systemic, biological) and phototherapy, 
the concern in the literature generally focuses on secondary aspects of psoriasis and 
its associated comorbidities. Although psoriasis is considered a psychodermatosis 
with relevant morbidity and their physiopathological mechanisms are increasingly 
involved in multi factorial processes (for example, infl ammatory mechanisms and 
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their connection to stress), one realizes that the recommendations for treatment are 
reduced to the forms described above. Accordingly, the aim of this work is to verify 
the psychological and educational interventions performed in the treatment of psoriasis, 
whether used as the sole treatment or as an adjunct to other therapies. As far as we are 
concerned, no other study attempted to systematically search this kind of intervention 
involving psoriatic patients.
Method
A systematic review in English and Spanish including the last 20 years (1992 through 
June 30, 2012) was performed in the databases of PubMed / Medline, PsycInfo (APA), 
and ProQuest Pepsic (Psychology Journals) including the term psoriasis combined with 
psychological intervention, educative intervention, psychotherapy and psychotherapy 
protocol. The searches were performed by a research assistant under de supervivion of 
a library technician from PUCRS University, who was specialized in database search. 
Interventions designed for psoriasis and other chronic dermatosis were included, provided 
that psoriasis was also included in the study. The exclusion criteria were: language other 
than the chosen, exclusively pharmacological interventions or phototherapy, literature 
review articles, case studies and cross-sectional studies evaluating psychosocial variables 
without psychological or educational intervention. It is considered psychological 
intervention treatments involving some techniques or approaches of cognitive/emotional/
psychological change, such as stress management and guided imagery; the educational 
interventions did not involve changes on cognitive variables, only informational or 
behavioral variables.
Results
Initially, the computerized search indicated a total of 257 items, which were 
subsequently selected to have their abstracts read. Exclusion criteria at this stage 
involved correlational and review studies. Among these, 36 manuscripts were selected 
to be fully read by two assessors, all written in English language; after being completely 
read, 29 articles were excluded (22 were medical/physiological interventions and seven 
were not empirical psychological interventions) only seven studies were subsequently 
selected for the fi nal analysis. Figure 1 shows the fl ow diagram of selected studies). 
The full review of potentially eligible articles were examined independently by two 
authors who were not blinded for the study´s criteria. Disagreements were resolved 
by consensus.
Aletheia 42, set./dez. 201314
Figure 1. Flow diagram illustrating published literature on educative and psychological intervention in pso-
riasis.
Computerized search of literature 
N = 1359




Manuscripts excluded by abstract 
n = 221
Manuscripts not meeting criterea 
n = 29
Manuscripts selected by consensus 
n = 7
Revisor 1 Revisor 2
Potencial manuscripts (full review)
n = 36
A brief appreciative review on the seven studies is presented as follows.
Individual cognitive-behavioral intervention – Zachariae et al, 1996
In this Danish study patients with psoriasis were randomly assigned to two groups: 
experimental and control. Experimental group consisted of 25 patients and underwent 
seven sessions of cognitive-behavioral intervention involving stress management, 
relaxation techniques and symptom control imagery training. The patients underwent a 
washout period of 14 days before the start of the study and were monitored at baseline and 
at the weeks four, eight and 12. The experimental group of 23 patients who completed the 
intervention showed a reduction of lesions compared to the control group by PASI (p = 
0.06), the difference being that the percentage reduction in the PASI group was signifi cant 
(p <.05). The results showed a satisfactory effect of psychological intervention, since 
there was no signifi cant difference in the measurements obtained in the control group. 
Overall, 74% of patients in the experimental group improved symptoms, whereas the 
improvement was 43% for the controls.
A pilot hypnosis intervention – Tausk & Whitmore, 1999
This is a pilot study involving 11 patients with stable plaque psoriasis in the 12 
months prior to the start of the study, without medication, divided into two groups. In the 
experimental group (n = 5) patients received suggestions for improvement of symptoms 
of psoriasis during hypnosis sessions. The control group (n = 6) received neutral hypnosis 
interventions, consisting only of suggestions aimed at relaxation. In the group that received 
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the suggestions of symptom improvement, three subjects showed lesion improvement 
through PASI, decreased 81, 43 and 8%, respectively, all of which were among those who 
achieved the highest scores in the Stanford Scale of Hypnotizability. Of the six patients in 
the control group, the two persons who had the greatest reduction in lesions (31 and 18%, 
respectively) also had a higher score on the degree of hypnotizability, while moderately 
hypnotizable worsened 36 and 18%, respectively. Despite the modest sample presented, 
the study indicates that people with higher levels of suggestibility by hypnosis tend to 
get greater benefi ts in the clinical symptoms of psoriasis.
Study with the aid of audio tapes adjunct to phototherapy (UVB) and 
photochemotherapy (PUVA) – Kabat-Zinn et al., 1998
Patients with moderate and severe psoriasis (n = 37) were divided by medical 
indication into two groups, one receiving the phototherapy intervention only and another 
group with the use of psoralen added to phototherapy. The subjects were notifi ed that 
the research was testing whether the experience of listening to relaxing music during the 
sessions of phototherapy would be nicer. The intervention for the experimental group 
included mindfulness meditation instruction, involving breathing, awareness of sensations, 
sounds, lights and air streams. At the end of the tape, they were also instructed to imagine 
that UV rays would be decreasing the growth and division of the skin. Four indicators 
for monitoring the reduction of lesions were created: fi rst response point (fi rst perceived 
change in lesions), turning point (plate begins to decrease area), halfway point (halfway 
through the initial injury) and clearing point (less than 5% of the initial lesions). The results 
point to differences between the groups with and without the use of relaxation tapes, the 
fi rst 3.8 x more likely to reach the half point (p = 0.013) and point of whitening (p = 0.033). 
Furthermore, individuals in the tape group showed higher scores of positivity towards the 
sessions, a greater degree of relaxation and greater optimism towards treatment.
Symptom-management program – Fortune et al, 2002
This manuscript refers to the adaptation of the symptom management program 
offered by the NHS (National Health System) in the UK, previously structured for chronic 
pain, now adapted for psoriasis (PSMP – Psoriasis Symptom Management Programme). 
Amongst the psoriasis patients who were offered the program, 93 subjects were randomized 
into two groups by preference, one with conventional medical treatment (control) and 
the other with a multidisciplinary program. The intervention consisted of six cognitive-
behavioral sessions, with 2.5h each, performed by doctors, nurses and psychologists. 
Measures taken at baseline, six weeks and six months were the following: extent of 
lesions (PASI), anxiety and depression (HADS – Hospital Anxiety and Depression Scale), 
stress (PLSI – Psoriasis Life Stress Inventory) and degree of disability (PDI – Psoriasis 
Disability Index). Of the 93 people who agreed to participate in the study, 40 participated 
in the PSMP and 53 were part of the control group. The results showed that the PASI 
signifi cantly reduced at six weeks and six months (p <0.001), as well as the levels of 
anxiety (p <0.001) and depression (p <0.001) and disability (p = 0.04). Another fi nding 
reveals that, from the patients who participated in the program, 64% obtained clearance 
(> 75%), compared with only 23% of the control group.
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Multidisciplinary educational program for chronic dermatosis – Lambert et al., 2011
This article was referring to a pilot study of the department of dermatology at 
the Hospital Ghent, Belgium, to test a multidisciplinary program aimed at improving 
the quality of life of patients with chronic dermatosis. The program lasted 12 weeks 
(2 meetings / week), and the psychological and educational activities were included 
in the following topics: skin care, Stress Reduction techniques, life style factors and 
psychodermatology information. A multidisciplinary team was composed of physical 
educator, dermatologist, nurse, teacher of yoga and mindfulness meditation, psychiatrist, 
psychologist and philosopher. Patients with psoriasis (n = 17) showed signifi cant 
improvement in measures of quality of life after the intervention of the DLQI (p = 
0.015), Skindex-29 (p = 0.020) and decreased their disability index with the PDI (p 
= 0.019).
Single Educative Intervention – Lora, Gisondi, Calza, Zanoni & Girolomoni, 2009
This manuscript portrays an educational intervention designed by a team of 
dermatology of Verona, Italy. Participants (n = 123) were randomized by computer 
to receive educational intervention of two hours by a dermatologist (educational 
group) or the psychoeducational group, where a psychologist accompanied the same 
2h of intervention. The part that was up to the doctor was to explore the various 
information about psoriasis with the patient, such as the mechanisms of the disease, 
precipitating factors, course of disease, preventive measures and daily skin care. The 
group that had the presence of psychologists during the intervention received the same 
information, however, the end of the consultation was reserved so that they could be 
worked on possible negative emotions and coping strategies. Measures of quality of 
life (Skindex-29) and severity of pruritus were taken before and after the intervention, 
in addition to a six-month follow-up, where a telephone interview sought to verify that 
the information had been retained. The results showed an improvement in items that 
measured knowledge about the disease after six months (p <0.001) and a signifi cant 
increase in the perception that professionals have enough to treat the disease (p <0.001). 
The items that measured how the person felt comfortable with psoriasis or to deal with 
the symptoms revealed no signifi cant differences in both groups and in all outlets. The 
average PASI of the educational groups and psychoeducational groups were 9.8 and 
10.8, respectively.
Randomized controlled trial using a multidisciplinary program – Bostoen, Bracke, 
Keuser & Lambert, 2012
The Ghent Program intervention, previously mentioned, was again applied in 
patients with psoriasis and atopic dermatitis. This study involved 29 patients with 
psoriasis, previously randomized by computer, and divided into control and experimental 
group. The former continued to receive conventional medical treatment alone, while 
the second received the multidisciplinary approach of the program. The measures of 
extent and severity (PASI), quality of life (Skindex-29), level of disability (PDI) and 
depression (BDI – Beck Depression Inventory) were assessed at baseline and three, 
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six and nine months later. The results of PASI indicated a signifi cant reduction of 
lesions in the experimental group compared to controls at three months (P = 0.036) 
and six months post-intervention (p = 0.017), although the reduction has not been 
maintained at nine months (p = 0.116). Psoriasis disability index showed a reduction 
at all times, three months (p = 0.015) and six months (p = 0.020) and nine months (p 
= 0.021), whereas the average overall rates of depression decreased signifi cantly after 
nine months (p = 0.029).
Discussion
We performed a systematic review of the past 20 years about the psychological and 
educational interventions presented for the treatment of psoriasis. Although we have a 
consolidated scientifi c literature in the fi elds of psychosomatic and psychodermatology 
pointing to the importance of including psychological therapies and educational 
interventions for psoriasis, there is a noteworthy low number of articles found. Of 
the seven articles analyzed, fi ve of them were created especially for the treatment of 
psoriasis, while two of them were aimed at the chronic dermatosis most commonly 
linked to psychosomatic aspects. Overall, we observed a reduced number of subjects 
who participated in the studies, which, on one hand, may indicate the diffi culties 
of conducting interventional research, such as the high dropout rates. On the other 
hand, these data can hypothetically show poor adherence of patients for this type of 
intervention, since traditional treatments are offered on a larger scale and are part of 
the current medical standard. Only one study had a randomized clinical trial, which 
refl ects the need to conduct further research with more rigorous methodologies. Due 
to the nature of the intervention, double-blind studies were not found, but only four 
of the seven manuscripts reported that either the professionals that performed medical 
tests or some of the patients’ choices were blind.
In all selected studies the results were satisfactory in almost unanimity of the 
psychological variables. Clinical examination in one study (Zachariae et al., 1996) 
showed no signifi cant improvement of the lesions in the control group, although this 
has shown close to signifi cant levels. More recent studies have accessed instruments to 
evaluate health-related variables, such as quality of life and degree of disability of the 
disease, which shows a recent trend in studies with psoriasis. The variables depression 
and anxiety, that have long been associated with psoriasis, were measured in only two 
studies (Fortune et al., 2002; Bostoen et al., 2012), which may refl ect a recent trend 
of researchers seeking broader tools that allow accessing psychosocial variables. In 
this sense, we can see as well the specialization of scales used in more recent studies, 
which showed instruments specifi cally designed for use in psoriatic patients, such as 
the DLQI, PDI and PLSI. The degree of specialization of instrumentation used and the 
small number of studies involving psychological and educational interventions may 
refl ect the emphasis in studies that focus on cross-cutting research designs.
The individual interventions have proved to be the majority and the modality 
of choice in four of the seven studies. Techniques were used in these various 
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interventions, such as psychotherapy, hypnosis, guided imagery and psychoeducation, 
but all these were not accompanied by further studies that could confi rm the 
results with a larger sample and in other populations. It is clear, also, a tendency of 
recent literature on the use of the group modality and the use of multidisciplinary 
interventions involving the management of symptoms. In the United Kingdom, as 
seen in Fortune and colleagues (Fortune et al., 2002), management programs for 
chronic symptoms have long been developed, as this program has been adapted for 
pain. Another European program with twice the time of intervention, developed by 
the Ghent Hospital from Belgium (Lambert et al., 2011; Bostoen et al., 2012), is 
another example of the tendency of interventions having a multidisciplinary and 
educational nature. The three manuscripts have applied these two programs used 
at least four different health professionals, refl ecting the interdisciplinary nature of 
these approaches. It can be hypothesized that the low investment of recent research 
on individual interventions is due to satisfactory results and to government support 
for the development of such programs, which would be contemplating the results 
brought by multidimensional literature.
Although most studies use clinical and psychological variables to measure aspects 
of psoriasis in the evaluation of interventions, none of the studies used biological 
variables. The markers used in biological studies involving psoriasis are often related 
to stress effects, such as: serum cortisol (Evers et al., 2010), salivary cortisol (Remrod 
et al., 2007), interleukin1β (Mastrolonardo, Alicino, Zefferino, Pasquini & Picardi, 
2007) and NK cells (Schmidt-Ott et al., 2009). It is believed that this discrepancy in 
relation to intervention studies may be related to the fact that PNI is a relatively new 
area of research, and the education of health professionals are not yet contemplating 
interdisciplinary aspects, focusing only on their specialty. Perhaps this explains both the 
diffi culty of conducting interdisciplinary intervention studies as well as the professional 
lack of preparation (Picardi et al., 2004; Richards et al., 2004; Jefferany et al., 2010) 
and disappointment by some patients in an outpatient level (Magin et al., 2009), since 
psoriasis is a chronic disease that affects individuals in their multiple dimensions. 
Likewise, none of the analyzed studies took into account important individual variables 
such as gender, age of onset of psoriasis and coping strategies.
Conclusion
This was the fi rst review article that, among its range of 20 years, intended to 
analyze the psychological and educational interventions available for psoriasis, including 
interventions for chronic dermatosis where there were patients with psoriasis. However, 
several limitations of this manuscript could be pointed. Exclusion criteria may have left 
some manuscript not contemplated for analysis in this review, as well as the limitation 
of these authors in understanding other languages. The limited data and the reduced 
number of articles prevented a quantitative analysis of the results, which affected the 
quality of the systematic review. Brief comments were made on each study due to the 
limited information available and little methodological strictness, which makes this 
analysis somewhat limited.
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Prospective studies could benefi t from the use of biological variables, contributing to 
the etiopathogenic understanding of psoriasis as to the validation of different intervention 
techniques. There is a clear need for investment in interdisciplinary interventions for 
psoriasis, given the degree of commitment of the individuals affected by the disease and 
the amount of data that point to different psychosocial variables as important matters 
both in genesis, exacerbation and injury. Other studies could bring the importance of 
the infl ammatory nature of diseases as psoriasis and may be involved in a chain of 
infl ammatory illnesses in the long term, as Christophers (2007) brings. Accordingly, 
psoriasis would have an even greater importance, not only for its damage itself, but 
by the inherent risk of developing more severe infl ammatory diseases, subject to early 
intervention.
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